Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Standard versus radical pancreaticoduodenectomy for periampullary adenocarcinoma

Researchers in the January issue of the Journal of Gastrointestinal Surgery find no differences in long-term quality of life, between standard and radical resection for periampullary adenocarcinoma.

News image

fiogf49gjkf04

Pancreaticoduodenectomy is increasingly performed for periampullary adenocarcinoma. However, the appropriate extent of resection (standard versus radical) remains controversial, particularly with respect to survival benefit.

Past reports have suggested that radical resection is attended by negative functional outcomes and poorer health-related quality of life (QOL). This diminishes any possible survival advantage of the radical resection.

In this study, researchers from Baltimore, Maryland, assessed the QOL of patients who were randomly allocated to 1 of 2 treatments. Patients received either standard, or radical pancreaticoduodenectomy, for periampullary adenocarcinoma.

The research team performed a prospective, randomized single-institution trial. They compared standard and radical pancreaticoduodenectomy in 299 patients, between 1996 and 2001.

A standard Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) QOL survey, designed for hepatobiliary cancer, was sent to 150 of the 299 patients.

QOL and functional status were assessed via a series of subscale scores for physical, social, emotional, and functional well-being.

The team analyzed 105 of the surveys. The team randomized 55 of the patients the standard group, and 50 to the radical group.

The patients were evaluated at a mean of 2.2 years after pancreaticoduodenectomy.

The quality of life survey scores were similar between the groups.
Journal of Gastrointestinal Surgery
The research team found that the 2 groups were statistically similar with regard to multiple parameters. These included age at operation, race, intraoperative blood transfusions, pathologic diagnosis and staging, and perioperative complications.

However, the radical group had a significantly higher percentage of men (66% versus 44%), a longer operative time, and a longer postoperative length of hospital stay.

The team determined that the FACT-Hep total QOL scores were similar between both groups.

In addition, subscale scores evaluating physical, social, emotional, and functional well-being were comparable between the standard and radical groups.

The team found that subgroup analyses based on pathologic diagnosis failed to reveal any differences in QOL assessment between the groups.

Furthermore, QOL measures were similar when comparing time since operation and age.

Dr Tom Nguyen's team concluded, "This is the largest report comparing QOL assessment in survivors of pancreaticoduodenectomy randomized between standard and radical resection".

"These data demonstrate no differences in long-term QOL between standard and radical resection."

"These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma."

J Gastrointest Surg 2003; 7: 1-11
28 January 2003

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us